Welcome, financially savvy (or not-so-savvy) readers, to another round of investment musings where we explore the deep recesses of ultra-cheap dividend stocks. You know, the kind of stocks that yield more cash than your bank savings account could ever dream of—unless, of course, you enjoy the thrilling annual interest of 0.03%. Today, we dive into three dividend stocks for December that promise fat yields, low valuations, and maybe even a sprinkle of hope. Let’s see if these deals are truly “ultra” or just “meh.” 1. Merck (NYSE: MRK) – The Old Reliable Merck is the friend who always shows up to the party with potato chips: not particularly exciting, but dependable. This pharmaceutical giant offers a dividend yield of 3.2%, which is about as thrilling as a lukewarm latte, but hey, it beats the S&P 500 average of 1.2%. Why Merck Might Be Worth It Keytruda’s Curtain Call: Merck’s star drug, Keytruda, brought in a casual $25 billion last year. It’s a big deal, but the patent is set t...